TGTX
Tg Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.42 / 10
Underperform
Fundamental picture is unfavorable (score 2.4/10). Key strengths include a healthy Interest coverage ratio (4.08) and positive Profit-MV. However, critical weaknesses dominate: high Days sales outstanding (125.71) signaling collection inefficiency, elevated PB-ROE (4.49) suggesting overvaluation, and negative Cash-MV (-0.07). These factors collectively point to operational and valuation risks that outweigh the positives.
Analysis Checks(6/10)
Revenue-MV
Value-1.34
Score1/3
Weight12.21%
1M Return4.24%
Value-1.34
Score1/3
Weight12.21%
1M Return4.24%
Days sales outstanding
Value125.71
Score0/3
Weight-10.75%
1M Return-5.18%
Value125.71
Score0/3
Weight-10.75%
1M Return-5.18%
Net income-Revenue
Value2.78
Score2/3
Weight24.28%
1M Return8.45%
Value2.78
Score2/3
Weight24.28%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value4.08
Score2/3
Weight-2.43%
1M Return-1.11%
Value4.08
Score2/3
Weight-2.43%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value91.88
Score2/3
Weight2.60%
1M Return1.11%
Value91.88
Score2/3
Weight2.60%
1M Return1.11%
Profit-MV
Value1.31
Score2/3
Weight24.25%
1M Return8.45%
Value1.31
Score2/3
Weight24.25%
1M Return8.45%
PB-ROE
Value4.49
Score0/3
Weight7.24%
1M Return2.72%
Value4.49
Score0/3
Weight7.24%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value91.88
Score2/3
Weight1.00%
1M Return0.43%
Value91.88
Score2/3
Weight1.00%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight23.85%
1M Return8.41%
Value-0.07
Score2/3
Weight23.85%
1M Return8.41%
Revenue-MV
Value-1.34
Score1/3
Weight12.21%
1M Return4.24%
Value-1.34
Score1/3
Weight12.21%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value91.88
Score2/3
Weight2.60%
1M Return1.11%
Value91.88
Score2/3
Weight2.60%
1M Return1.11%
Days sales outstanding
Value125.71
Score0/3
Weight-10.75%
1M Return-5.18%
Value125.71
Score0/3
Weight-10.75%
1M Return-5.18%
Profit-MV
Value1.31
Score2/3
Weight24.25%
1M Return8.45%
Value1.31
Score2/3
Weight24.25%
1M Return8.45%
Net income-Revenue
Value2.78
Score2/3
Weight24.28%
1M Return8.45%
Value2.78
Score2/3
Weight24.28%
1M Return8.45%
PB-ROE
Value4.49
Score0/3
Weight7.24%
1M Return2.72%
Value4.49
Score0/3
Weight7.24%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value4.08
Score2/3
Weight-2.43%
1M Return-1.11%
Value4.08
Score2/3
Weight-2.43%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value91.88
Score2/3
Weight1.00%
1M Return0.43%
Value91.88
Score2/3
Weight1.00%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight23.85%
1M Return8.41%
Value-0.07
Score2/3
Weight23.85%
1M Return8.41%
Is TGTX undervalued or overvalued?
- TGTX scores 2.42/10 on fundamentals and holds a Premium valuation at present. Backed by its 102.25% ROE, 84.13% net margin, 75.74 P/E ratio, 7.54 P/B ratio, and 3160.00% earnings growth, these metrics solidify its Underperform investment rating.
